Broadfin Capital
North America, New York, United States, New York
Description
Broadfin Capital is a New-York-based company focused on investments in healthcare companies.
Investor Profile
Broadfin Capital has backed more than 13 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 8% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, Ireland, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Post Ipo Equity (77%)
- Series Unknown (15%)
- Series C (8%)
Country Focus
- United States (77%)
- Ireland (8%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Israel (8%)
- Canada (8%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Health Diagnostics
- Therapeutics
- Oncology
- Clinical Trials
- Alternative Medicine
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
